CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Thousands	12 Months Ended
Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
OPERATING ACTIVITIES:
Net (loss) income	$ (14,056)	$ 3,406	$ (7,950)
Adjustments to reconcile net income to net cash provided by (used for) operating activities:
Depreciation	26,687	27,823	27,309
Amortization, including accretion and write-off of deferred financing costs	8,055	6,648	5,926
Deferred income taxes	(5,110)	(511)	(7,953)
Loss (earnings) of equity method investee	823	(3,658)	(1,536)
(Gain) loss on sale of fixed assets	(241)	(165)	185
Share-based compensation expense	5,942	5,960	5,888
Excess tax deficiency (benefit) related to share-based compensation expense	543	(563)	(46)
Gain on sale of Canton Facility, net	0	(30,718)	0
Gain on disposal of business and joint venture, net	0	(2,942)	0
Property, plant and equipment impairment charge	33	0	2,349
Change in fair value of earn-out contingent consideration	0	2,065	(3,196)
Changes in operating assets and liabilities:
Accounts receivable, net	(13,161)	(17,019)	4,164
Inventories, net	(20,127)	(51,270)	4,000
Prepaid expenses and other assets	(5,159)	(5,116)	1,342
Accounts payable	18,489	16,515	3,642
Accrued expenses and other liabilities	4,088	13,297	(5,483)
Net cash provided by (used for) operating activities	6,806	(36,248)	28,641
INVESTING ACTIVITIES:
Capital expenditures, including intangibles	(31,609)	(27,031)	(32,462)
Proceeds from sale of fixed assets	158	268	127
Proceeds from settlement of net investment hedges	3,820	0	0
Proceeds from disposal of business, net	0	1,837	0
Proceeds from disposal of joint venture, net	0	20,999	0
Proceeds from sale of Canton Facility, net	0	35,167	0
Investment in venture capital fund, net	(950)	(3,199)	(1,550)
Net cash (used for) provided by investing activities	(28,581)	28,041	(33,885)
FINANCING ACTIVITIES:
Revolving credit facility borrowings	21,562	91,913	71,500
Revolving credit facility payments	(18,000)	(64,000)	(61,500)
Proceeds from issuance of debt	38,940	45,753	41,104
Repayments of debt	(42,732)	(48,125)	(37,823)
Earn-out consideration cash payment	(6,276)	0	0
Common Share repurchase program	0	0	(4,995)
Repurchase of Common Shares to satisfy employee tax withholding	(791)	(2,665)	(1,773)
Net cash (used for) provided by financing activities	(7,297)	22,876	6,513
Effect of exchange rate changes on cash and cash equivalents	(1,677)	(3,041)	3,247
Net change in cash and cash equivalents	(30,749)	11,628	4,516
Cash and cash equivalents at beginning of period	85,547	73,919	69,403
Cash and cash equivalents at end of period	54,798	85,547	73,919
Supplemental disclosure of cash flow information:
Cash paid for interest	7,293	6,055	5,620
Cash paid for income taxes, net	6,178	11,267	(254)
Supplemental disclosure of non-cash activities:
Adoption of ASU 2019-12 (Note 2)	$ 0	$ 0	$ 13,750

The aggregate expense charged against earnings to allocate the cost of intangible assets including deferred financing costs (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. Also included in this amount is the accretion of the debt discount and the deferred financing costs which are a component of interest expense representing the periodic charge against earnings to reflect amortization of debt discounts and deferred financing costs over the life of the related debt instrument. As a noncash expense, this element is added back to net income when calculating cash provided by (used in) operations using the indirect method.

No definition available.